← Browse by Condition
Medical Condition

small cell lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05947851 Phase 3
Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

Enrollment
735 pts
Location
United States, Argen...
Sponsor
Merck Sharp & Dohme LLC
View Trial →